COM:ALEMBICPHARMACEUTICALS
Alembic Pharmaceuticals
- Stock
Last Close
1,123.85
05/11 09:59
Market Cap
196.41B
Beta: -
Volume Today
55.68K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '14 | Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 18.20B - | 20.10B 10.43% | 30.55B 51.99% | 30.30B 0.82% | 30.35B 0.16% | 38.07B 25.42% | 44.92B 18.00% | 52.76B 17.46% | 52.32B 0.84% | 56.53B 8.04% | 62.29B 10.19% | |
cost of revenue | 7.59B - | 7.58B 0.12% | 8.43B 11.12% | 10.37B 23.11% | 10.62B 2.40% | 11.93B 12.36% | 13.14B 10.12% | 15.21B 15.76% | 17.23B 13.27% | 17.09B 0.83% | 34.34B 100.96% | |
gross profit | 10.61B - | 12.52B 17.98% | 22.12B 76.75% | 19.93B 9.93% | 19.73B 1.00% | 26.13B 32.46% | 31.78B 21.61% | 37.55B 18.16% | 35.09B 6.56% | 39.44B 12.40% | 27.95B 29.14% | |
selling and marketing expenses | 1.94B - | 2.45B 26.11% | 2.74B 11.85% | 3.93B 43.65% | 3.80B 3.28% | 5.90B 55.18% | 5.31B 9.97% | 6.96B 31.07% | 8.90B 27.88% | 9.52B 6.95% | ||
general and administrative expenses | 331.94M - | 423.50M 27.59% | 517.36M 22.16% | 1.45B 180.02% | 1.10B 23.93% | 1.35B 22.57% | 1.55B 14.84% | 2.09B 34.52% | 2.11B 1.11% | 2.41B 14.25% | ||
selling general and administrative expenses | 2.27B - | 2.87B 26.32% | 3.25B 13.37% | 5.38B 65.33% | 4.90B 8.84% | 7.25B 47.85% | 6.86B 5.35% | 9.05B 31.85% | 11.01B 21.71% | 11.93B 8.35% | 21.34B 78.82% | |
research and development expenses | 1.16B - | 1.22B 4.46% | 3.07B 152.47% | 982M 68.02% | 368.60M 62.46% | 302.70M 17.88% | 426.40M 40.87% | 253.80M 40.48% | 505.90M 99.33% | 290.70M 42.54% | ||
other expenses | 10.04M - | 17.32M 72.48% | 6.74B 38,800.17% | 2.50M 99.96% | 300K 88% | 2.30M 666.67% | 200K 91.30% | 2M 900% | 1.30M 35% | 27.40M 2,007.69% | ||
cost and expenses | 14.99B - | 16.57B 10.52% | 21.19B 27.91% | 24.91B 17.54% | 25.25B 1.38% | 30.49B 20.75% | 33.81B 10.88% | 39.79B 17.70% | 46.39B 16.58% | 52.20B 12.51% | 55.68B 6.67% | |
operating expenses | 7.40B - | 8.99B 21.43% | 12.77B 42.08% | 14.54B 13.86% | 14.63B 0.65% | 18.56B 26.84% | 20.67B 11.37% | 24.58B 18.93% | 29.16B 18.63% | 35.11B 20.40% | 21.34B 39.22% | |
interest expense | 104.00M - | 38.08M 63.39% | 42.73M 12.22% | 51.20M 19.82% | 34M 33.59% | 184.10M 441.47% | 271.60M 47.53% | 160.20M 41.02% | 177.30M 10.67% | 501.70M 182.97% | 561.90M 12.00% | |
ebitda | 3.59B - | 4.07B 13.22% | 10.11B 148.39% | 6.14B 39.26% | 6.45B 5.02% | 8.95B 38.86% | 12.25B 36.84% | 15.59B 27.32% | 9.26B 40.65% | 6.80B 26.51% | 9.33B 37.22% | |
operating income | 3.21B - | 3.53B 10.03% | 9.36B 164.95% | 5.39B 42.38% | 5.10B 5.44% | 7.41B 45.40% | 11.11B 49.92% | 12.97B 16.68% | 5.87B 54.70% | 4.38B 25.48% | 6.61B 50.92% | |
depreciation and amortization | 404.87M - | 444.13M 9.70% | 722.14M 62.60% | 829.70M 14.90% | 1.05B 27.11% | 1.15B 9.26% | 1.57B 36.53% | 1.83B 16.62% | 2.87B 56.31% | 2.75B 3.96% | 2.73B 1.00% | |
total other income expenses net | -103.67M - | 58.86M 156.78% | -1.48M 102.52% | -138.40M 9,238.73% | 314.20M 327.02% | -12.80M 104.07% | -1.12B 8,613.28% | 1.03B 192.33% | 379.30M 63.17% | -831.80M 319.30% | -278.80M 66.48% | |
income before tax | 3.11B - | 3.59B 15.60% | 9.36B 160.56% | 5.25B 43.85% | 5.41B 3.03% | 7.49B 38.44% | 10.00B 33.43% | 13.68B 36.83% | 6.20B 54.67% | 3.55B 42.82% | 6.33B 78.46% | |
income tax expense | 751.03M - | 763.49M 1.66% | 2.16B 182.93% | 1.22B 43.43% | 1.20B 1.51% | 1.57B 30.25% | 1.99B 27.07% | 2.53B 27.18% | 1.04B 58.76% | 126.10M 87.93% | 160M 26.88% | |
net income | 2.36B - | 2.83B 20.13% | 7.19B 154.29% | 4.03B 43.96% | 4.13B 2.35% | 5.84B 41.62% | 8.29B 41.83% | 11.46B 38.33% | 5.21B 54.56% | 3.42B 34.35% | 6.16B 80.07% | |
weighted average shs out | 188.56M - | 188.49M 0.04% | 188.52M 0.01% | 188.52M 0% | 188.52M 0% | 188.52M 0% | 188.52M 0% | 193.74M 2.77% | 196.56M 1.46% | 196.56M 0% | ||
weighted average shs out dil | 188.56M - | 188.49M 0.04% | 188.52M 0.01% | 188.52M 0% | 188.52M 0% | 188.52M 0% | 188.52M 0% | 193.74M 2.77% | 196.56M 1.46% | 196.56M 0% | ||
eps | 12.49 - | 15.01 20.18% | 38.19 154.43% | 21.39 43.99% | 21.89 2.34% | 31 41.62% | 43.97 41.84% | 59.18 34.59% | 26.50 55.22% | 17.40 34.34% | 31.33 80.06% | |
epsdiluted | 12.49 - | 15.01 20.18% | 38.19 154.43% | 21.39 43.99% | 21.89 2.34% | 31 41.62% | 43.97 41.84% | 59.18 34.59% | 26.50 55.22% | 17.40 34.34% | 31.33 80.06% |
All numbers in (except ratios and percentages)